Lortab and Pentoxifylline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lortab (acetaminophen; hydrocodone bitartrate) and Pentoxifylline (pentoxifylline). Common drug interactions include upper respiratory tract infection among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Lortab and Pentoxifylline. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Lortab?

Lortab has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 31,285 Lortab users. Check the latest studies of Lortab.

What is Pentoxifylline?

Pentoxifylline has active ingredients of pentoxifylline. eHealthMe is studying from 5,997 Pentoxifylline users. Check the latest studies of Pentoxifylline.



On Jul, 15, 2026

37 people who take Lortab and Pentoxifylline together, and have interactions are studied.

Lortab and Pentoxifylline drug interactions.

What are the common drug interactions of Lortab and Pentoxifylline, by gender? *:

female:

  1. Upper respiratory tract infection
  2. Atypical mycobacterial infection (infections caused by several types of mycobacterium similar to the germ that causes tuberculosis)
  3. Bacterial infection
  4. Benign hepatic neoplasm (benign (non-cancerous) tumours of the liver)
  5. Blood cholesterol increased
  6. Cardiolipin antibody positive
  7. Diverticular perforation (serious gastrointestinal condition in which the intestine's walls are perforated)
  8. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  9. Furuncle (infection of the hair follicle)
  10. Gastrointestinal stoma complication (complication of an opening surgically made in digestive tract)

male:

  1. Anaemia (lack of blood)
  2. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  3. Bone disorder
  4. Bone fragmentation
  5. Bone marrow reticulin fibrosis (thickening and scarring of bone marrow reticulin)
  6. Bone swelling
  7. Cardiac failure congestive
  8. Cellulitis (infection under the skin)
  9. Chest pain
  10. Dental caries

What are the common drug interactions of Lortab and Pentoxifylline, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anxiety
  2. Benign hepatic neoplasm (benign (non-cancerous) tumours of the liver)
  3. Cardiolipin antibody positive
  4. Chest pain
  5. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  6. Pain in extremity
  7. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  8. Anisocytosis (patient's red blood cells are of unequal size)
  9. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  10. Blood cholesterol increased

50-59:

  1. Decreased appetite
  2. Diverticular perforation (serious gastrointestinal condition in which the intestine's walls are perforated)
  3. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  4. Fatigue (feeling of tiredness)
  5. Furuncle (infection of the hair follicle)
  6. Gastrointestinal stoma complication (complication of an opening surgically made in digestive tract)
  7. Hot flushes (sudden feelings of heat)
  8. Incision site infection (infection at incision site)
  9. Ligament sprain (ligament stretched)
  10. Mycobacterium marinum infection (a free-living bacterium, which causes opportunistic infections in humans)

60+:

  1. Cellulitis (infection under the skin)
  2. Anaemia (lack of blood)
  3. Blood cholesterol increased
  4. Bone disorder
  5. Bone fragmentation
  6. Bone marrow reticulin fibrosis (thickening and scarring of bone marrow reticulin)
  7. Bone swelling
  8. Cardiac failure congestive
  9. Chest pain
  10. Dental caries

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 18 people, 48.65%
  2. Trismus (reduced opening of the jaws): 16 people, 43.24%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 8.11%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.41%
  5. Polyp: 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Lortab and Pentoxifylline?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lortab and Pentoxifylline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lortab:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pentoxifylline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lortab and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pentoxifylline and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; hydrocodone bitartrate and pentoxifylline (the active ingredients of Lortab and Pentoxifylline, respectively), and Lortab and Pentoxifylline (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: